FDA’s Rare Disease Innovation Hub Releases Strategic Agenda: Implications for Stakeholders in 2025
In honor of Rare Disease Day on February 28, 2025, we will publish a series of posts throughout the month on As Prescribed ...
His research explores the rise of generative AI and accelerated use of AI more broadly to advance drug and scientific discovery. Reuben leads Gartner's coverage of genomics, multiomics, cell and gene ...
Medical Xpress on MSN9d
Study Finds Three New Safe, Effective Ways To Treat Drug-Resistant TuberculosisA third drug, pretomanid, received emergency authorization from the FDA for specific use within a regimen against highly drug ...
Key Drivers of Market Expansion The demand for effective antibacterial therapies is being bolstered by the growing global burden of infectious diseases. With the emergence of drug-resistant bacteria, ...
IRA has unintended consequences on investment landscape for small- and large-molecule drugs stifling the development of new ...
The FDA has said it will create a rare disease innovation hub to help speed the ... The hub will focus in particular on diseases that affect very small patient populations and those where the ...
The integration of Artificial Intelligence (AI) into the medical field marks a groundbreaking shift, with expectations that ...
Critical pain points need to be overcome for the animal healthcare industry to achieve its full potential.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback